AN INVESTIGATION OF THE CLINICAL IMPACT OF BETA2-AGONIST USE IN HEART FAILURE

被引：0
|
作者：
Bermingham, M. [1 ]
O'Callaghan, E. [1 ]
Dawkins, I [1 ]
Miwa, S. [1 ]
Samsudin, S. [1 ]
McDonald, K. [1 ]
Ledwidge, M. [1 ]
机构：
[1] St Vincents Univ Hosp, Heart Failure Unit, Dublin 4, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2010年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
10
引用
收藏
页码：S388 / S388
页数：1
相关论文
共 50 条
  • [21] Use of Beta Blockers in Heart Failure: The Impact of Race on the Efficacy of Beta Blocker Therapy
    Busuioc, Monica
    Shore, Supriya
    Aggarwal, Vikas
    Zolty, Ronald
    [J]. CIRCULATION, 2011, 124 (21)
  • [22] Dopamine agonist use and the risk of heart failure
    Renoux, Christel
    Dell'Aniello, Sophie
    Brophy, James M.
    Suissa, Samy
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (01) : 34 - 41
  • [23] Inhaled Beta2-Agonist Increases Power Output and Glycolysis during Sprinting in Men
    Kalsen, Anders
    Hostrup, Morten
    Soderlund, Karin
    Karlsson, Sebastian
    Backer, Vibeke
    Bangsbo, Jens
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2016, 48 (01): : 39 - 48
  • [24] Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk
    Brook, Robert D.
    Anderson, Julie A.
    Calverley, Peter M. A.
    Celli, Bartolome R.
    Crim, Courtney
    Denvir, Martin A.
    Magder, Sheldon
    Martinez, Fernando J.
    Rajagopalan, Sanjay
    Vestbo, Jorgen
    Yates, Julie
    Newby, David E.
    [J]. HEART, 2017, 103 (19) : 1536 - 1542
  • [25] CROSS-OVER COMPARISON STUDY ON THE PREVENTIVE EFFECT OF CROMOLYN SODIUM, BETA2-AGONIST TABLET, BETA2-AGONIST AEROSOL, AND WARM-UP IN CHILDREN WITH EXERCISE-INDUCED ASTHMA (EIA)
    KIM, KE
    LEE, SY
    JEOUNG, BJ
    LEE, KY
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (01) : 247 - 247
  • [26] EXPOSURE TO SYSTEMIC CORTICOSTEROIDS AMONG US PATENTS ASTHMA: RISKS ASSOCIATED WITH SHORT-ACTING BETA2-AGONIST USE
    Lanz, Miguel J.
    Pollack, Michael
    Gilbert, Ileen
    Gandhi, Hitesh N.
    Tkacz, Joseph
    Lugogo, Njira L.
    [J]. CHEST, 2022, 162 (04) : 48A - 49A
  • [27] Short-Acting Beta2-Agonist Use in Asthma in Korea: A 10-Year Population-Based Study
    Lee, Hyun
    Ryu, Jiin
    Chung, Sung Jun
    Yeo, Yoomi
    Park, Tai Sun
    Park, Dong Won
    Moon, Ji-Yong
    Kim, Tae-Hyung
    Sohn, Jang Won
    Yoon, Ho Joo
    Kim, Sang-Heon
    [J]. ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2021, 13 (06) : 945 - 953
  • [28] Predictors of excessive short-acting beta2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database
    Kupczyk, Maciej
    Barg, Wojciech
    Bochenek, Grazyna
    Brozek, Grzegorz
    Brzostek, Dorota
    Dabrowiecki, Piotr
    Dabrowski, Andrzej
    Dobek, Rafal
    Gawlik, Radoslaw
    Kucharczyk, Aleksandra
    Kuprys-Lipinska, Izabela
    Mastalerz-Migas, Agnieszka
    Zagrajek, Edyta
    Kowalski, Marek L.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [29] Treatment of heart failure with Celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties
    Witchitz, S
    Cohen-Solal, A
    Dartois, N
    Weisslinger, N
    Juste, K
    Darmon, JY
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (12): : 1467 - 1471
  • [30] Assessing Asthma Control in the United States by Examining the Relationships Between Short-Acting Beta2-Agonist and Systemic Corticosteroid Use
    Bleecker, E. R.
    Murphy, K. R.
    Gandhi, H. N.
    Gilbert, I.
    Chupp, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345